Axi-Cel Moves Toward the First-Line Setting for High-Risk Large B-Cell Lymphoma
Are patients who have received fewer prior medications better candidates for the receipt of CAR-T therapies?
Katarina Zimmer, MSci, MS
Katarina Zimmer, MSci, MS, is a science and environmental journalist based in New York. Her work has appeared in The Scientist, National Geographic, Grist, and elsewhere.
